1. Home
  2. ABEO vs MTA Comparison

ABEO vs MTA Comparison

Compare ABEO & MTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • MTA
  • Stock Information
  • Founded
  • ABEO 1974
  • MTA 1983
  • Country
  • ABEO United States
  • MTA Canada
  • Employees
  • ABEO N/A
  • MTA N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • MTA
  • Sector
  • ABEO Health Care
  • MTA
  • Exchange
  • ABEO Nasdaq
  • MTA Nasdaq
  • Market Cap
  • ABEO 332.0M
  • MTA 391.4M
  • IPO Year
  • ABEO 1980
  • MTA N/A
  • Fundamental
  • Price
  • ABEO $6.26
  • MTA $4.30
  • Analyst Decision
  • ABEO Strong Buy
  • MTA Hold
  • Analyst Count
  • ABEO 6
  • MTA 1
  • Target Price
  • ABEO $18.00
  • MTA $4.50
  • AVG Volume (30 Days)
  • ABEO 611.9K
  • MTA 355.1K
  • Earning Date
  • ABEO 08-19-2025
  • MTA 08-18-2025
  • Dividend Yield
  • ABEO N/A
  • MTA N/A
  • EPS Growth
  • ABEO N/A
  • MTA N/A
  • EPS
  • ABEO N/A
  • MTA N/A
  • Revenue
  • ABEO N/A
  • MTA $6,348,000.00
  • Revenue This Year
  • ABEO N/A
  • MTA $115.15
  • Revenue Next Year
  • ABEO $322.37
  • MTA $71.94
  • P/E Ratio
  • ABEO N/A
  • MTA N/A
  • Revenue Growth
  • ABEO N/A
  • MTA 30.38
  • 52 Week Low
  • ABEO $3.93
  • MTA $2.45
  • 52 Week High
  • ABEO $7.32
  • MTA $4.34
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 47.50
  • MTA 60.21
  • Support Level
  • ABEO $6.18
  • MTA $4.15
  • Resistance Level
  • ABEO $6.94
  • MTA $4.33
  • Average True Range (ATR)
  • ABEO 0.27
  • MTA 0.16
  • MACD
  • ABEO -0.05
  • MTA -0.01
  • Stochastic Oscillator
  • ABEO 18.07
  • MTA 91.35

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About MTA Metalla Royalty & Streaming Ltd.

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.

Share on Social Networks: